Xegen Overview

  • Founded
  • 2012

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Xegen General Information


Developer of bioinformatics tools designed for exhaustive genetic information. The company's platform gives access to all the coding parts of the genome and provides a large overview of coding variations and their phenotypes' consequences, providing physicians with transcriptomic information such as differential expression at a reduced cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Medical Supplies
Primary Office
  • 15 Rue Dominique Piazza
  • Cedex 20
  • 13420 Marseille
  • France
+33 06 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xegen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Xegen’s complete valuation and funding history, request access »

Xegen Executive Team (3)

Name Title Board Seat Contact Info
Julien Paganini Ph.D Co-Founder, Chief Executive Officer & President
Philippe Gouret Ph.D Co-Founder & Chief Technology Officer
Pierre Pontarotti Ph.D Co-Founder & Scientific advisor
To view Xegen’s complete executive team members history, request access »

Xegen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
To view Xegen’s complete investors history, request access »